Photo from wikipedia
Epstein‐Barr virus (EBV) infection is prevalent in global population and associated with multiple malignancies and autoimmune diseases. During the infection, EBV‐harbored or infected cell‐expressing antigen could elicit a variety of… Click to show full abstract
Epstein‐Barr virus (EBV) infection is prevalent in global population and associated with multiple malignancies and autoimmune diseases. During the infection, EBV‐harbored or infected cell‐expressing antigen could elicit a variety of antibodies with significant role in viral host response and pathogenesis. These antibodies have been extensively evaluated and found to be valuable in predicting disease diagnosis and prognosis, exploring disease mechanisms, and developing antiviral agents. In this review, we discuss the versatile roles of EBV antibodies as important biomarkers for EBV‐related diseases, potential driving factors of autoimmunity, and promising therapeutic agents for viral infection and pathogenesis.
Journal Title: Journal of Medical Virology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!